30
Participants
Start Date
March 31, 2008
Primary Completion Date
October 31, 2010
Study Completion Date
August 31, 2011
MPC-6827 + Carboplatin
MPC-6827 at 2.1mg/m2, 2.7mg/m2 or 3.3mg/m2 administered by intravenous infusion over 2 hours once weekly for three weeks in a 4 week cycle. Carboplatin at AUC4 administered by intravenous infusion over 1 hour on Day 1 of each 4 week cycle.
Mt. Sinai School of Medicine, New York
Emory University, Atlanta
University of Texas MD Anderson Cancer Center, Houston
Huntsman Cancer Institute at the University of Utah, Salt Lake City
The Angeles Clinic and Research Institute, Los Angeles
Lead Sponsor
Myrexis Inc.
INDUSTRY